CLINICAL_TRIALS
research
· 2025-09-05
Clinical Trial Update: Energetics and Glutamate in Schizophrenia
Summary
An ongoing clinical trial funded by King's College London is examining brain energetics and glutamate signaling in schizophrenia. The study is currently recruit…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: King's College London | Conditions: Schizophrenia | Status: RECRUITING